Botulinum toxin (BTX-A)

Legal Issues in Aesthetic Dermatology: What Dermatologists Should Know
Aesthetic Dermatology
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Mathew M. Avram  (Director of the Mass General Dermatology Laser & Cosmetic Center and Director of Dermatologic Surgery at MGH, as well as Faculty Director for Procedural Training in Harvard Medical School's Dermatology Department), who discusses potential legal situations that may ari …

Continue reading "Legal Issues in Aesthetic Dermatology: What Dermatologists Should Know"

Severe Ulcerative Perniosis Treated With Botulinum Toxin
Botulinum Toxin
by NEXT STEPS IN DERM TEAM on
Perniosis (also known as pernio or chilblains), is a condition characterized by the development of pruritic, painful erythrocyanotic skin lesions induced by exposure to cold temperatures.² When perniosis occurs in conjunction with clinical or laboratory features of systemic lupus erythematosus, the condition is further classified as chilblain lupus erythematosus (CHLE). CHLE is a rare condition w …

Continue reading "Severe Ulcerative Perniosis Treated With Botulinum Toxin"

Botulinum Toxin in the Long-Term Treatment of Refractory Raynaud’s Phenomenon
Refractory Raynaud’s Phenomenon
by NEXT STEPS IN DERM TEAM on
Raynaud’s phenomenon is an exaggerated physiological response of blood vessels in the distal extremities to emotional stress and cold. It can be idiopathic or secondary to a connective tissue disorder, such as scleroderma or systemic lupus erythematosus. Treatment for Raynaud’s phenomenon consists primarily of lifestyle modifications; if unsuccessful, pharmacotherapy with dihydropyridine calci …

Continue reading "Botulinum Toxin in the Long-Term Treatment of Refractory Raynaud’s Phenomenon"